Posts by: Janet Stewart, MSc

Janet Stewart, MSc

Janet Stewart is a life sciences writer and editor, who completed both PhD course work and oral examinations in the Department of Microbiology and Immunology at McGill University, and holds an M.Sc. in Virology and Immunology.

July 16, 2018

Pregnant Women Who Develop AAV May Safely Be Treated with Rituxan, Case Report Suggests

News

Pregnant women who develop ANCA-associated vasculitis (AAV) may safely receive Rituxan (rituximab) and corticosteroids, a case study suggests. However, this is the first study describing Rituxan’s use in pregnant women ... Read more

July 3, 2018

InflaRx Set to Launch Phase 2 Trial Testing IFX-1 in AAV Patients Following FDA Approval

News

InflaRx will soon begin a Phase 2 clinical trial assessing the safety and effectiveness of IFX-1 — an inhibitor of the complement system — in patients with ANCA-associated vasculitis (AAV). This ... Read more

April 24, 2018April 24, 2018

Some Patients with Hydralazine-related AAV Develop Advanced Kidney Disease, Study Finds

News

Some patients with ANCA-associated vasculitis (AAV) caused by hydralazine — a medication used to treat high blood pressure — develop end-stage kidney disease, even after discontinuing the medicine and receiving immunosuppressive therapy, ... Read more

January 30, 2018

Study Reveals Why Autoantibodies ‘Disappear’ in Lesions of MPO-positive AAV Patients

News

A new study found why some patients with ANCA-associated vasculitis (AAV) have autoantibodies in the blood, but not at the sites of injury. This matter has puzzled scientists for ... Read more

December 18, 2017

GSK’s Nucala Approved by FDA as Add-on Therapy for EGPA Patients

News

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on to standard care for treating eosinophilic granulomatosis with polyangiitis (EGPA), previously called Churg-Strauss syndrome. “Patients ... Read more

October 3, 2017October 3, 2017

Staphylococcus Genes May Play Role in AAV Onset and Progression, Dutch Study Finds

News

Dutch scientists have identified different genes in Staphylococcus aureus — a kind of bacteria carried in the nostrils — in either patients with PR3-ANCA vasculitis or with MPO-ANCA-positive vasculitis. The results ... Read more

September 28, 2017

Experts Review Diagnosis, Treatment of ANCA Glomerulonephritis and Vasculitis

News

A review about the anti-neutrophil cytoplasmic antibody (ANCA) glomerulonephritis and vasculitis outlined the best way to characterize the different kinds of ANCA-associated disease in order to provide better treatment. The ... Read more